Compugen Ltd (CGEN) stock
CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.10−0.02 (-0.94%)
Close on Nov 13, 2026Market cap $198.56MP/E 5.5Yield –
Compugen enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Compugen's enterprise value was $148.01M on Nov 11, 2026, against $110.57M a year earlier. Over the last 5 years it ranged from $36.24M to $352.32M, with a median of $117.49M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $148.01M | +37.3% |
| 2025 | Dec 31, 2025 | $107.77M | +16.6% |
| 2024 | Dec 31, 2024 | $92.42M | -39.4% |
| 2023 | Dec 29, 2023 | $152.47M | +184.3% |
| 2022 | Dec 30, 2022 | $53.63M | -84.8% |
| 2021 | Dec 31, 2021 | $352.32M | -64.4% |
| 2020 | Dec 31, 2020 | $988.32M | +172.2% |
| 2019 | Dec 31, 2019 | $363.03M | +220.8% |
| 2018 | Dec 31, 2018 | $113.18M | +3.0% |
| 2017 | Dec 29, 2017 | $109.87M | -54.3% |
| 2016 | Dec 30, 2016 | $240.20M | -23.2% |
| 2015 | Dec 31, 2015 | $312.86M | +4.1% |
| 2014 | Dec 31, 2014 | $300.50M | -9.0% |
| 2013 | Dec 31, 2013 | $330.24M | +96.2% |
| 2012 | Dec 31, 2012 | $168.29M | +4.8% |
| 2011 | Dec 30, 2011 | $160.58M | +9.6% |
| 2010 | Dec 31, 2010 | $146.57M | – |
See a number that looks wrong?